VENOUS THROMBOEMBOLISM
Clinical trials for VENOUS THROMBOEMBOLISM explained in plain language.
Never miss a new study
Get alerted when new VENOUS THROMBOEMBOLISM trials appear
Sign up with your email to follow new studies for VENOUS THROMBOEMBOLISM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cheap statin could slash deadly clot risk in cancer patients
Prevention Not yet recruitingThis study tests whether taking rosuvastatin (a statin) daily for one year can safely prevent life-threatening blood clots in people with cancer. About 4,000 adults with newly diagnosed or relapsed cancer who are at high risk for clots will receive either the drug or a placebo. T…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: PHASE4 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated May 26, 2026 03:20 UTC
-
Could a stronger blood thinner dose save trauma patients from deadly clots?
Prevention Not yet recruitingThis study looks at whether giving a higher dose of the blood thinner enoxaparin can better prevent dangerous blood clots in the legs or lungs of severely injured patients. About 540 adults in intensive care after trauma will receive either the standard or a double dose. The goal…
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Prevention
Last updated May 19, 2026 12:00 UTC
-
Hidden danger: could a simple test save heart failure patients from deadly clots?
Knowledge-focused Not yet recruitingThis study looks at whether dangerous blood clots in the lungs (pulmonary embolism) are often missed in people hospitalized with acute heart failure. Both conditions cause similar symptoms like sudden shortness of breath, making diagnosis tricky. The study will compare hospitals …
Matched conditions: VENOUS THROMBOEMBOLISM
Phase: NA • Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated May 26, 2026 03:21 UTC
-
New study tracks blood thinner safety in infants and toddlers
Knowledge-focused Not yet recruitingThis study looks at how blood thinners like rivaroxaban are used in children under 2 years old who have blood clots. Researchers will collect information from medical records and insurance claims to see how well these medicines work and if they cause serious bleeding. No extra te…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Bayer • Aim: Knowledge-focused
Last updated May 26, 2026 03:13 UTC
-
Arm or belly? study seeks best spot for blood clot prevention in severe obesity
Knowledge-focused Not yet recruitingThis study looks at whether injecting the blood thinner enoxaparin into the arm or the belly works better for preventing dangerous blood clots in people with severe obesity (BMI over 40). About 80 adults will take part, and researchers will measure drug levels in the blood to see…
Matched conditions: VENOUS THROMBOEMBOLISM
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC